Adjuvant chemo(immuno-)-therapy of primary breast cancer with adriamycin-cyclophosphamide (and levamisole)—Six-year evaluation
- 1 May 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (5) , 607-613
- https://doi.org/10.1016/0277-5379(83)90176-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Attempt at Quantification of the Cytotoxic Drug-Induced Changes of the Human Bone Marrow CompartmentsScandinavian Journal of Haematology, 2009
- Adjuvant Intermittent Chemoimmunotherapy for Primary Breast Cancer: A Prospective Study with Immunologic Follow-UpPublished by Springer Nature ,1982
- Disease-free survival at intervals during and following completion of adjuvant chemotherapy: The NSABP experience from three breast cancer protocolsCancer, 1981
- Changes of Granulopoiesis during and after Adjuvant Chemotherapy of Breast CancerBritish Journal of Haematology, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- LEVAMISOLE IN ADVANCED HUMAN BREAST CANCERThe Lancet, 1976
- Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancerCancer, 1975
- L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast CancerNew England Journal of Medicine, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958